- Home
- MGIC vs HUMAW Comparison
MGIC vs HUMAW Comparison
Compare MGIC & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGIC | HUMAW |
|---|---|---|
| Founded | 1983 | 2004 |
| Country | Israel | United States |
| Employees | N/A | 220 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.3M | N/A |
| IPO Year | 1991 | N/A |
Fundamental Metrics
Financial Performance| Metric | MGIC | HUMAW |
|---|---|---|
| Price | $26.74 | $0.15 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 40.9K | 14.2K |
| Earning Date | 11-18-2025 | 03-21-2025 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | ★ 16.15 | N/A |
| EPS | ★ 0.81 | N/A |
| Revenue | ★ $603,216,000.00 | N/A |
| Revenue This Year | $12.87 | N/A |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | $32.98 | ★ N/A |
| Revenue Growth | ★ 12.65 | N/A |
| 52 Week Low | $11.36 | $1.18 |
| 52 Week High | $27.00 | $1.34 |
Technical Indicators
Market Signals| Indicator | MGIC | HUMAW |
|---|---|---|
| Relative Strength Index (RSI) | 71.24 | 44.95 |
| Support Level | $24.82 | $0.11 |
| Resistance Level | $27.00 | $0.15 |
| Average True Range (ATR) | 0.70 | 0.03 |
| MACD | 0.21 | 0.00 |
| Stochastic Oscillator | 92.53 | 91.78 |
Price Performance
Historical ComparisonAbout MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.